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Vascular access and increased risk of death among hemodialy- patients has not been extensively studied. A study of
sis patients. hemodialysis patients who began treatment between
Background. Hemodialysis with a venous catheter increases 1986 and 1987 found that percutaneous venous cathetersthe risk of infection. The extent to which venous catheters are
were associated with a 60% increased risk of septicemiaassociated with an increased risk of death among hemodialysis
among non-diabetic patients during seven years of fol-patients has not been extensively studied.
Methods. We conducted a retrospective cohort study of 7497 low-up and that hospitalization for sepsis was associated
prevalent hemodialysis patients to assess the association be- with an increased risk of death [4]. However, the long
tween dialysis with a venous catheter and risk of death due to duration of follow-up in this study makes it difficult to
all causes and to infection.
infer an association between the use of percutaneousResults. A tunneled cuffed catheter was used for access in
venous catheters and subsequent risk of death, since in12% of the patients and non-cuffed, not tunneled catheter in
2%. Younger age (P 0.0005), black race (P 0.0022), female many cases the deaths occurred long after the period of
gender (P 0.0004), short duration since starting dialysis (P catheter use. The purpose of this study was to examine
0.0003) and impaired functional status (P 0.0001) were inde- the association between venous catheter access for he-
pendently associated with increased use of catheter access. The
modialysis and risk of subsequent all-cause and cause-proportion of patients who died was higher among those who
specific mortality among prevalent end-stage renal dis-were dialyzed with a non-cuffed (16.8%) or cuffed (15.2%)
ease (ESRD) patients over a relatively short period ofcatheter compared to those dialyzed with either a graft (9.1%)
or a fistula (7.3%; P  0.001). The proportion of deaths due follow-up.
to infection was higher among patients dialyzed with a catheter
(3.4%) compared to those dialyzed with either a graft (1.2%)
or a fistula (0.8%; P 0.001). The adjusted odds ratio (95% CI) METHODS
for all-cause and infection-related death among patients dialyzed Study designwith a catheter was 1.4 (1.1, 1.9) and 3.0 (1.4, 6.6), respectively,
compared to those with an arteriovenous (AV) fistula. A retrospective cohort study of prevalent hemodialy-
Conclusion. Venous catheters are associated with an in- sis patients was conducted to assess the association be-
creased risk of all-cause and infection-related mortality among tween at least one dialysis treatment with a percutaneous
hemodialysis patients.
venous catheter and subsequent risk of death due to all-
causes and to infection.
Vascular access through a venous catheter for hemodi- Study setting
alysis is associated with increased risk of thrombosis, Information was obtained on all 279 hemodialysis
central venous stenosis, short access survival and inade- treatment facilities in North Carolina, South Carolina
quate dialysis [1, 2]. In particular, venous catheters are and Georgia that reported to ESRD Network 6 as of
associated with increased rates of infection, including January 1, 1998. Thirty patients (or all patients if the
bacteremia, osteomyelitis and endocarditis compared to facility census of patients was less than thirty) receiving
other types of vascular access [3]. Despite the fact that hemodialysis at each treatment center were randomly
infection is a leading cause of death among dialysis pa- selected by ESRD Network staff for inclusion in a hemo-
tients, the extent to which venous catheters are associ- dialysis survey. All patients in the survey aged 18 years
ated with an increased risk of death among hemodialysis and older were eligible for inclusion in our study.
Data collectionKey words: dialysis, mortality, venous catheter, infection, arterioven-
ous fistula, graft access. The survey forms were mailed to the dialysis facilities
in April 1998. For each selected patient, staff at the 2002 by the International Society of Nephrology
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facilities recorded the most recent pre- and post-treat- outcome and the other model used death from infectious
causes only as the outcome event. Both models also in-ment blood urea nitrogen (BUN) measurements made
for routine monitoring of hemodialysis adequacy. In ad- cluded age, sex, race, diabetic ESRD, functional status,
serum albumin, comorbidity, delivered time, blood flowdition, staff recorded height, pre- and post-dialysis weight,
type of vascular access used (graft, fistula, tunneled cuffed rate and URR, so that the influence of these characteris-
tics could be adjusted for in the analyses. Further, varia-catheter and non-cuffed, not tunneled catheter), and the
blood flow and actual delivered time of the dialysis ses- tions in duration of time since onset of ESRD among our
prevalent patients were accounted for by including thesion during which the BUN measurements were made.
The most recent hematocrit, serum albumin level, and length of time on dialysis as a covariate. In addition, in
order to measure the effect of catheter use on mortalitytransferrin saturation measurements and the most re-
cent assessment of the patient’s functional status (non- among the high-risk diabetic population, the analyses on
the subset of the study population with diabetes were re-impaired  able to perform all usual activities; mildly
impaired  able to perform all but strenuous activi- peated either as a cause of their ESRD or as a comorbid
condition. Because the results of proportional hazardsties; moderately impaired  unable to perform usual
activities; and severely impaired  severe limitation of regression and logistic regression analyses were the same,
we report the results of logistic regression only [5, 6].physical activities) was also abstracted from the pa-
tient’s chart. Finally, analyses of the association between catheter
use and the risk of death that accounted for the potentialThe urea reduction ratio (URR) was calculated as
followings: correlation of risk within individual treatment centers
were done. We accounted for potential center effects by
URR  {[BUNpre  BUNpost]/BUNpre} * 100 (Eq. 1) using the general linear modeling program (Proc Gen-
mod), a SAS statistical software module (SAS Institute,There was no standardized methodology employed
across facilities to obtain the post-dialysis blood spec- Cary, NC, USA) [7]. In these analyses, the treatment
imen. center was the grouping variable. All analyses were con-
ESRD Network 6 routinely collects and continually ducted using SAS statistical software [7].
updates patient demographic and clinical characteristics
abstracted by dialysis center staff from treatment center
RESULTSrecords. Patient characteristics used for the analysis in-
Adequacy data were collected during a dialysis sessioncluded age, race, sex, diabetes as the primary cause of
that took place in April or May 1998 for 96% of therenal failure, and comorbidity (angina pectoris, myocar-
patient sample, and usable data were available for 7403dial infarction and congestive heart failure).
of the 7497 patients randomly selected for study. The
Follow-up reasons for the 94 exclusions were: BUN data not col-
lected within three months of 6/1/98 for 10 patients; in-For this study, follow-up for each patient whose data
complete measurement of BUN for 73 patients; and datawere collected as part of the adequacy survey began
on age, race, or sex were missing for 11 patients. Theon the day that adequacy measures were obtained and
mean  SEM number of patients sampled from eachcontinued until January 5, 1999. Patients were censored
facility was 26.5 0.39. The mean age of the hemodialy-at the time of transplant, transfer from the treatment
sis population estimated from the sample was 58.3  0.2center, or at the end of the study. Deaths were identified
years. Nearly three-fourths of the cohort was black,by monitoring death notification forms routinely submit-
about one-third had ESRD associated with diabetes, andted to the Network by dialysis facility staff and through
nearly a third had moderate or severe limitations in phys-quarterly censuses on all patients. Each death notifica-
ical activity (Table 1). The number (proportion) of pa-tion includes a list of causes of death and we defined an
tients with a graft was 4927 (66%); fistula, 1509 (20%);infectious death as one resulting from (1) septicemia
tunneled cuffed catheter, 824 (12%); and non-cuffed,from any source, (2) pulmonary infection, (3) viral infec-
not tunneled catheter, 137 (2%; Fig. 1).tion, (4) tuberculosis, (5) AIDS, or (6) other infection.
Associations between the type of vascular access and
Data analysis other patient characteristics are shown in Table 1. The
younger and older patients were somewhat more likelyDifferences in the distribution of vascular access types
to have a catheter for vascular access. Blacks were lessacross levels of patient characteristics were examined for
likely to have a catheter for access (12%) compared tostatistical significance in univariate analyses using chi-
whites (15%; P  0.002) and males (11.4%) were lesssquare tests and in multivariate analyses using logistic
likely than females (14.5%; P 0.001) to be dialyzed withregression. Then, two multivariate models were used to
a catheter. The prevalence of catheter use increased asexamine the associations between vascular access type
and death: one model used death from all causes as the functional status declined, with 8% of the non-impaired
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Table 1. Distribution of patient characteristics and associations with vascular access type in a random sample
of 7403 hemodialysis patients in ESRD Network 6, October 1998
Number (%) patients
Catheter
Factor Total (%) Uncuffed Cuffed Graft Fistula
Age years
49 1841 (24.9) 39 (2.1) 198 (10.8) 1058 (57.5) 544 (29.6)a
49–60 1849 (25.0) 34 (1.8) 180 (9.7) 1244 (67.3) 390 (21.1)
61–70 1856 (25.1) 32 (1.7) 187 (10.1) 1320 (71.2) 316 (17.0)
71 1857 (25.1) 32 (1.7) 259 (14.0) 1305 (70.4) 259 (14.0)
Race
Black 5484 (74.1) 106 (1.9) 566 (10.3) 3780 (69.0) 1029 (18.8)a
White 1919 (25.9) 31 (1.6) 258 (13.5) 1147 (59.9) 480 (25.0)
Gender
Male 3581 (48.4) 78 (2.2) 329 (9.2) 2143 (59.9) 1029 (28.8)a
Female 3822 (51.6) 59 (1.6) 495 (13.0) 2784 (72.9) 480 (12.6)
Cause of ESRD
Other 4864 (65.7) 93 (1.9) 519 (10.7) 3085 (63.5) 1164 (24.0)a
Diabetes 2539 (34.3) 44 (1.7) 305 (12.0) 1842 (72.6) 345 (13.6)
Functional status
Non-impaired 2144 (29.0) 23 (1.1) 148 (6.9) 1314 (61.3) 657 (30.7)a
Mildly impaired 2730 (36.9) 48 (1.8) 243 (8.9) 1906 (69.9) 531 (19.5)
Moderately impaired 1443 (19.5) 43 (3.0) 206 (14.3) 1000 (69.4) 193 (13.4)
Severely impaired 1083 (14.6) 23 (2.1) 226 (20.9) 707 (65.3) 126 (11.6)
Angina pectoris
Yes 892 (12.1) 19 (2.1) 113 (12.7) 595 (66.7) 165 (18.5)
No 6505 (87.9) 118 (1.8) 711 (10.9) 4332 (66.6) 1344 (20.7)
Congestive heart failure
Yes 1572 (21.2) 21 (1.3) 208 (13.2) 1085 (69.0) 258 (16.4)a
No 5825 (78.8) 116 (2.0) 616 (10.6) 3842 (66.0) 1251 (21.5)
Myocardial infarction
Yes 603 (8.2) 9 (1.5) 80 (13.3) 407 (67.5) 107 (17.7)
No 6794 (91.8) 128 (1.9) 744 (11.0) 4520 (66.5) 1402 (20.6)
Albumin levelb g/dL
3.5 1515 (20.6) 40 (2.6) 241 (15.9) 995 (65.7) 239 (15.8)a
3.6–3.8 2168 (29.4) 41 (1.9) 226 (10.4) 1500 (69.2) 401 (18.5)
3.9–4.0 1608 (21.8) 26 (1.6) 141 (8.8) 1122 (69.8) 319 (19.8)
4.0 2075 (28.2) 29 (1.4) 214 (10.3) 1289 (62.1) 543 (26.2)
Hematocrit
30 1583 (21.7) 48 (3.0) 232 (14.7) 1015 (64.1) 288 (18.2)a
31–33 1853 (25.4) 37 (2.0) 188 (10.2) 1259 (67.9) 369 (19.9)
34–36 2151 (29.5) 34 (1.6) 208 (9.7) 1463 (68.0) 446 (20.7)
37 1715 (23.5) 18 (1.0) 185 (10.8) 1130 (65.9) 382 (22.3)
ESRD is end-stage renal disease.
a P  0.001 by 2 test indicating that the distribution of vascular access type was different between levels of the factor
b To convert g/dL to g/L multiply by 10
dialyzed by catheter access, compared to 10.7% for
mildly, 17.3% for moderately and 23% for severely im-
paired patients (P  0.001). Similarly, as albumin levels
declined the proportion of patients dialyzed with a cathe-
ter for vascular access increased (P  0.001).
Patient characteristics independently associated with
the presence of a cuffed catheter included younger age
(P  0.0005), lower serum albumin (P  0.04), black
race (P 0.002), female sex (P 0.0004), short duration
of ESRD (P  0.0003), and more severely impaired
functional status (P  0.0001). In contrast, myocardial
infarction, angina pectoris, congestive heart failure and
diabetic ESRD were not associated with an increased
likelihood of having a cuffed catheter. Patient character-
istics independently associated with the presence of aFig. 1. Distribution of vascular access use among 7403 dialysis patients
in the ESRD Network 6 in 1998. non-cuffed catheter included younger age (P  0.04),
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Table 2. Distribution of dialysis characteristics and associations with vascular access type in a random sample
of 7403 dialysis patients in ESRD Network 6, October 1998
Number (%) patients
Catheter
Factor Total (%) Uncuffed Cuffed Graft Fistula
URR
66.0 1834 (25.0) 73 (4.0) 293 (16.0) 1050 (57.3) 416 (22.7)a
66.1–70.5 1825 (24.9) 23 (1.3) 196 (10.8) 1224 (67.1) 381 (20.9)
70.6–74.5 1837 (25.1) 17 (0.9) 157 (8.6) 1303 (70.9) 360 (19.6)
74.6 1827 (24.9) 22 (1.2) 162 (8.9) 1299 (71.2) 341 (18.7)
Delivered time minutes
193 1642 (22.2) 32 (2.0) 173 (10.6) 1173 (71.6) 261 (15.9)a
194–210 2188 (29.6) 31 (1.4) 205 (9.4) 1541 (70.5) 409 (18.7)
211–240 2633 (35.6) 54 (2.0) 298 (11.3) 1687 (64.1) 593 (22.5)
241 940 (12.7) 20 (2.1) 148 (15.7) 526 (56.0) 246 (26.2)
Blood flow rate cc/min
400 1623 (21.9) 90 (5.6) 500 (30.8) 746 (46.0) 286 (17.6)a
400 2826 (38.2) 26 (0.9) 226 (8.0) 2010 (71.2) 562 (19.9)
401–450 1559 (21.1) 13 (0.8) 71 (4.6) 1123 (72.2) 349 (22.4)
451 1394 (18.8) 8 (0.6) 27 (1.9) 1047 (75.1) 312 (22.4)
Dialysis duration years
1.80 1558 (22.2) 29 (1.9) 215 (13.8) 999 (64.2) 314 (20.2)a
1.81–3.14 1785 (25.5) 34 (1.9) 202 (11.3) 1222 (68.5) 326 (18.3)
3.15–5.35 1829 (26.1) 34 (1.9) 199 (10.9) 1265 (69.3) 327 (17.9)
5.36 1838 (26.2) 33 (1.8) 173 (9.4) 1195 (65.0) 437 (23.8)
Abbreviations are: ESRD, end-stage renal disease; URR, urea reduction ratio.
a P  0.001 by 2 test indicating that the distribution of vascular access type was different between levels of the factor
male sex (P  0.0004), short duration of ESRD (P  a fistula, 125 had a cuffed catheter, and 23 had a non-
cuffed catheter. The proportion of patients who died0.04), and impaired functional status (P  0.0002). Fac-
tors not associated with the presence of a non-cuffed during follow-up was higher among patients dialyzed
with a non-cuffed (16.8%) or cuffed (15.2%) cathetercatheter included myocardial infarction, angina pectoris,
congestive heart failure, diabetic ESRD, race, serum al- compared to those dialyzed with either a graft (9.1%)
or a fistula (7.3%; P  0.001) (Fig. 2). Of the 672 deathsbumin level, and duration of ESRD.
The characteristics of the dialysis prescription are that occurred, 103 (15.3%) were attributed to infectious
causes. Similarly, the proportion of deaths due to infec-shown in Table 2. The mean URR  SD for the cohort
was 69.9  8.1 and the mean URR was lower among tion was higher among patients dialyzed with a catheter
(3.4%) compared to those dialyzed with either a graftpatients dialyzed with a non-cuffed (63.9) or cuffed cath-
eter (67.9) compared to those dialyzed with either a graft (1.2%) or a fistula (0.8%; P  0.001; Fig. 3). The unad-
justed odds of death from all causes (OR, 95% CI) were(70.6) or a fistula (69.5; P  0.001). The mean  SD
time of dialysis for the cohort was 217.7  42.4 minutes higher among patients who had a catheter compared to
patients with either a fistula (2.3, 1.8 to 3.0) or a graftand varied among patients dialyzed with a non-cuffed
(219.8) or cuffed catheter (221.1) compared to those (1.8, 1.5 to 2.2).
Demographic and other clinical characteristics inde-dialyzed with either a graft (215.3) or a fistula (223.5;
P  0.001). The mean  SD blood flow rate during pendently associated with an increased risk of all-cause
mortality included length of time on dialysis, increaseddialysis for the cohort was 410.8  65.8 cc/min and was
lower among patients dialyzed with a non-cuffed (328.6) age, white race, impaired functional status, decreased
albumin level, URR and a history of congestive heartor cuffed catheter (345.9) compared to those dialyzed
with either a graft (421.7) or a fistula (418.1; P  0.001). failure or myocardial infarction (Table 3). After control-
ling for these characteristics using a logistic regressionFinally, there was an inverse association between the
duration since the onset of dialysis in years and use of model, use of catheters remained associated with risk of
death (Table 3). For patients with a catheter, compareda vascular catheter for access. The mean  SD duration
of dialysis for the cohort was 4.26  3.5 years and was to those dialyzed with an arteriovenous (AV) fistula, the
OR (95% CI) of death was 1.4 (1.1 to 1.9). The increasedshorter among patients dialyzed with a non-cuffed (4.1)
or cuffed catheter (3.9) compared to those dialyzed with risk of death associated with catheter use was not influ-
enced by the choice of referent category because wheneither a graft (4.2) or a fistula (4.8; P  0.001).
During the follow-up period, 672 (9.1%) patients died. compared to patients with an AV graft, the OR (95%
CI) of death for patients with a catheter was 1.3 (1.1 toAmong the patients who died, 450 had a graft, 110 had
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Fig. 2. Crude mortality rate by vascular access type among 7403 dialysis Fig. 3. Crude mortality rate attributed to infection by vascular access
patients in the ESRD Network 6 in 1998. type among 7403 dialysis patients in the ESRD Network 6, in 1998.
Table 3. Associationsa between patient characteristics and vascular access type and the risk of all-cause and infection-related mortality
Odds ratio (95% CI)
All-cause mortality Infection-related mortality
Factor All patients Diabetics All patients Diabetics
Age per 10 year increase 1.15 (1.1, 1.2) 1.1 (0.9, 1.2) 1.1 (1.0, 1.4) 1.3 (0.9, 1.8)
White race vs. black 1.7 (1.4, 2.0) 1.8 (1.4, 2.5) 1.3 (0.8, 2.0) 2.2 (1.0, 4.5)
Male vs. female 1.3 (1.3, 1.5) 1.4 (1.1, 1.9) 0.9 (0.6, 1.4) 0.5 (0.2, 1.2)
Diabetic ESRD vs. other 1.0 (0.8, 1.2) — 1.0 (0.6, 1.6) —
Angina pectoris 0.9 (0.7, 1.1) 0.8 (0.5, 1.2) 0.7 (0.4, 1.5) 0.4 (0.1, 1.3)
Congestive heart failure 1.5 (1.3, 1.9) 1.6 (1.2, 2.2) 1.4 (0.9, 2.3) 1.2 (0.6, 2.6)
Myocardial infarction 1.5 (1.1, 1.9) 1.3 (0.8, 1.9) 0.9 (0.4, 2.1) 1.0 (0.3, 3.2)
Albumin level g/dL 0.5 (0.4, 0.6) 0.4 (0.3, 0.6) 0.4 (0.2, 0.6) 0.3 (0.1, 0.6)
Mild impaired function 1.4 (1.1, 1.9) 2.1 (1.2, 3.6) 0.6 (0.3, 1.3) 0.4 (0.1, 1.7)
Moderate impaired function 2.5 (1.9, 3.4) 2.7 (1.6, 4.7) 1.9 (0.9, 3.8) 1.1 (0.3, 3.8)
Severe impaired function 3.6 (2.7, 4.9) 4.0 (2.3, 6.8) 2.8 (1.4, 5.8) 2.0 (0.6, 6.4)
URR per 10% increase 0.9 (0.8, 1.0) 0.8 (0.7, 1.0) 0.8 (0.6, 1.0) 0.7 (0.5, 1.1)
HCT per 10% increase 0.9 (0.7, 1.1) 0.9 (0.7, 1.3) 1.4 (0.9, 2.2) 2.1 (1.0, 4.4)
Dialysis duration years 1.02 (1.0, 1.04) 1.1 (1.05, 1.2) 1.05 (1.0, 1.1) 1.2 (1.1, 1.4)
Vascular access type
Fistula Reference Reference Reference Reference
Graft 1.1 (0.9, 1.4) 1.2 (0.8, 1.9) 1.4 (0.6, 2.8) 3.9 (0.5, 30.0)
Catheter vs. fistula 1.4 (1.1, 1.9) 1.7 (1.0, 2.8) 3.0 (1.4, 6.6) 10.1 (1.3, 81)
Catheter vs. graft b 1.3 (1.1, 1.6) 1.4 (0.97, 1.9) 2.2 (1.4, 3.6) 2.6 (1.3, 5.3)
Abbreviations are: URR, urea reduction ratio; HCT, hematocrit.
a All factors were included in two logistic regression models; one model had death from all causes as the outcome and the second model had death from infection
only as the outcome
b In this model we used arteriovenous (AV) graft, rather than AV fistula, as the referent category for vascular access. Otherwise the model is identical to the
others presented in this table.
1.6). Finally, the adjusted OR for death among patients tion, were even stronger among patients with diabetes
(Table 3).dialyzed with a synthetic graft, compared to those with
an AV fistula, was 1.1 (0.9 to 1.4). Finally, we accounted for a possible center effect due
to similarities among patients within a single dialysisWhen the analysis was restricted to deaths attributed
to infections stronger associations were found between center. In these analyses, factors independently associ-
ated with an increased risk of all-cause mortality in-access type and risk of death (Table 3). In these analyses,
the OR (95% CI) of death due to infection for patients cluded: increased age, male gender, white race, impaired
functional status, decreased albumin level, URR and atreated with a catheter was 3.0 (1.4 to 6.6). The adjusted
OR for death due to infection among patients dialyzed history of congestive heart failure. In contrast to models
that did not account for center effect, the length of timewith a synthetic graft, compared to an AV fistula, was
1.4 (0.6 to 2.8). The associations between catheter use on dialysis and cormorbid myocardial infarction were no
longer associated with increased risk of death.and mortality from all causes, and especially for infec-
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There was no apparent center effect with respect to patients dialyzed with catheter access. The mortality rate
among incident dialysis patients is highest during thethe association between catheter use and the risk of mor-
tality relative to fistula use. The OR (95% CI) of 1.4 (1.04 first year of treatment [9, 10]. Catheters are often used
to provide treatment at the onset of dialysis therapy. Ato 1.9) was nearly identical to estimates that did not con-
trol for center effect, 1.4 (1.1 to 1.9; Table 3). Similarly, study of 1996 USRDS data revealed that the prevalence
of venous catheters was 18.9% at dialysis onset and sub-the odds of death among AV graft users compared to
fistula users, accounting for a possible center effect, were sequently declined to 12.9% within two months of start-
ing treatment as permanent access was established [11].comparable to estimates that did not account for center.
Khan et al reported an association between catheter use
and risk of death during the first 90 days of treatment
DISCUSSION
based on their observation that 78% of patients who died
Hemodialysis with a venous catheter increased the risk were dialyzed using catheters compared to only 21% of
of both all-cause and infection-related mortality in our those who survived [12]. However, even when we con-
patients. The increased risk persisted after controlling trolled for duration of treatment, a dialysis catheter re-
for other factors associated with mortality, including ade- mained a significant risk factor for death.
quacy of hemodialysis. While increased risk of morbidity Of particular note was our observation that both dia-
has been extensively reported with the use of venous betic and non-diabetic patients were at increased risk
catheters for hemodialysis access, this report and one by from deaths attributed to infection and that these risks,
Dhingra et al (abstract; J Am Soc Nephrol 11:182A, 2000) ranging from three- to tenfold, were quite substantial.
are the first to our knowledge to document an association The rate of bacteremia associated with dialysis catheters
between catheters and increased risk of all-cause death has been reported to be between two and four episodes
and deaths due to infection. Several factors might explain per 1000 catheter days [13–15]. Dittmer et al reported
the increased risk of death among individuals who are a high rate (68%) of bacterial colonization of dialysis
dialyzed through a catheter. One factor could be inade- catheters, with the mean time to positive culture of 27
quate dose of dialysis. We found that patients dialyzed days [16]. The bacteremia rate among colonized cathe-
via a catheter had a lower mean URR, lower blood flow ters was over 50% and the mean time to positive blood
rates and somewhat shorter treatment times. Lower culture was 32 days [16]. The risk of death associated
blood flow rates with catheter compared to AV access with an episode of catheter-associated bacteremia has
are well recognized, and a report from the USRDS found been reported to be 9% [17].
that the mean delivered Kt/V among patients with a Our findings have important implications for the care
venous catheter was 1.04 compared to 1.14 for those of hemodialysis patients. First, our data underscore the
receiving dialysis through an AV access [1, 8]. Although importance of placement of a non-catheter AV access
we accounted for URR and the treatment parameters as the preferred means for hemodialysis [1]. In many
delivered time and blood flow rate in our analysis, it is cases, catheters cannot support the blood flow rates nec-
possible that these cross-sectional measures fail to fully essary to achieve adequate dialysis therapy. Second, our
describe the differences in dose of dialysis associated findings support previous observations of increased mor-
with different access types. tality associated with catheter use. Efforts to prevent in-
A second factor might be the higher prevalence of fection are essential to lower mortality among patients
comorbid conditions among patients with catheters. For in whom a catheter must be placed for hemodialysis. Risk
example, vascular disease not only contributes to the factors for catheter-associated bacteremia, in addition to
exhaustion of peripheral arteries and veins for AV ac- diabetes mellitus, bacterial colonization and duration of
cess, but it is associated with increased mortality. How- catheterization, include frequency of manipulation, dress-
ever, after controlling for two measures of vascular dis- ing technique and the conditions of catheter placement
ease (angina and myocardial infarction) as well as for [3, 18]. Efforts to reduce infection rates should include
congestive heart failure, an increased risk of death asso- placement of the catheter in a sterile environment, ide-
ciated with catheter access was still found. While it is ally an operating room, proper exit site preparation by
possible that controlling for other comorbid conditions trained staff prior to use, and thorough cleaning of the
might have diminished the risks associated with catheter site with povidone iodine and application of a dry gauze
access that we observed, Dhinga et al (abstract; J Am Soc dressing after dialysis [1].
Nephrol 11:182A, 2000) found results comparable to Several limitations to our observations should be noted.
those reported here after controlling for additional co- First, while the Medicare data system provides for com-
morbid conditions including cancer and peripheral vas- plete ascertainment of death, the causes of death reported
cular disease. may not be accurate. It is possible that individuals with
It also is possible that the duration of ESRD might a venous catheter, because of the known association with
increased risk of infection, might be labeled as dying moreexplain some of the increased risk of mortality among
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